Anyone with the full paper, you probably have an email address...

Anyone with the full paper, you probably have an email address

http://www.sciencedirect.com/science/article/pii/S1051044316300240

Results

Of 40 patients, 29 (72.5%) underwent TARE; the most common reasons for not undergoing TARE were attenuated hepatic arteries (5/11), high pulmonary shunt (4/11), and poor arterial flow (2/11). Patients who underwent ≤ 4 chemoembolizations to the TARE target tended to be more likely to undergo TARE after mapping than patients who had > 4 chemoembolizations (P = .056). Most common grade ≥ 3 toxicities were fatigue (9/29; 31%) and biochemical alterations (bilirubin [3/29; 10.3%], albumin [4/29; 13.8%], aspartate aminotransferase [5/29; 17.2%]). Of 27 patients treated with TARE with follow-up, responses were 11 (41%) complete response, 5 (19%) partial response, 2 (7%) stable disease, and 9 (33%) progressive disease. Median progression-free survival and overall survival were 90 days and 257 days.
Conclusions

TARE is safe and effective salvage therapy in patients after chemoembolization. In patients who have undergone > 4 chemoembolizations to the ⁹⁰Y target, feasibility of TARE tends to be decreased.
Abbreviations

• BCLC, Barcelona Clinic Liver Cancer
• HCC, hepatocellular carcinoma
• TARE,transarterial radioembolization
• ⁹⁰Y, yttrium-90

Table 1
Table 1.

Figure 1.
Table 2
Table 2.
Table 3
Table 3.

Figure 2.

• D.S.H. received grants from GE Healthcare (Little Chalfont, United Kingdom), Philips Healthcare (Best, The Netherlands), and Society of Interventional Radiology Foundation (Fairfax, Virginia). S.A.P. reports personal fees from BTG International (Ottawa, Ontario, Canada) and Guerbet (Villepinte, France) outside the submitted work. None of the other authors have identified a conflict of interest.

• ⁎
  Address correspondence to G.E.J.

© 2016 SIR. Published by Elsevier Inc. All rights reserved.
Note to users: Corrected proofs are Articles in Press that contain the authors' corrections. Final citation details, e.g., volume/issue number, publication year and page numbers, still need to be added and the text might change before final publication.
Although corrected proofs do not have all bibliographic details available yet, they can already be cited using the year of online publication and the DOI , as follows: author(s), article title, journal (year), DOI. Please consult the journal's reference style for the exact appearance of these elements, abbreviation of journal names and use of punctuation.
When the final article is assigned to an issue of the journal, the Article in Press version will be removed and the final version will appear in the associated published issue of the journal. The date the article was first made available online will be carried over.
Citing articles (0)

• This article has not been cited.

Recommended articles

• Treatment Strategies for Hepatocellular Carcinoma in Cirrhosis
  
  2003Journal of Gastrointestinal Surgery
  1. W.Scott Helton, , Adrian Di Bisceglie, , Ravi Chari, , Myron Schwartz, , Jordi Bruix,
  DownloadPDF
• Atrial fibrillation influences survival in patients with hepatocellular carcinoma: Experience from a single center in Taiwan
  
  2014Journal of the Chinese Medical Association
  1. Tsung-Lin Yang, , Yu-Feng Hu, , Yenn-Jiang Lin, , Shih-Lin Chang, , Li-Wei Lo, , Ta-Chuan Tuan, , Tze-Fan Chao, , Fa-Po Chung, , Hao-Jan Lei, , Shih-Ann Chen,
  DownloadPDF
• Hepatocellular carcinoma
  
  2012The Lancet
  1. Maurice AAJ van den Bosch, , Luc Defreyne,
  DownloadPDF
• View more recommended articles »

Related book content

• Chapter 57 - Hepatocellular Carcinoma
  
  2012Zakim and Boyer's Hepatology (Sixth Edition)
  1. Jorge A. Marrero,
  DownloadPDF
• 14 - Tumours and tumour-like lesions of the liver
  
  2012MacSween's Pathology of the Liver (Sixth Edition)
  1. Zachary D. Goodman, , Luigi M. Terracciano, , Aileen Wee,
  DownloadPDF
• Treatment of hepatocellular carcinoma
  
  2002Perspectives in Medical Virology
  1. Alex Befeler, , Adrian M. Di Bisceglie,
  DownloadPDF
• View more articles »

• Outline
• Figures
• Export